corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 8599

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Campoy A.
Wyeth wins Arkansas hormone therapy trial
MarketWatch 2007 Feb 15
http://www.marketwatch.com/News/Story/Story.aspx?guid=%7b33C474FE-1AE0-4E68-8C0D-1EC6B23737F6%7d&siteid=yhoo&dist=yhoo


Full text:

SAN FRANCISCO (MarketWatch) — Wyeth (WYE : wyeth com WYE50.71, +0.04, +0.1%) after Thursday’s closing bell said an Arkansas jury found in favor of the company in a trial related to Wyeth’s hormone replacement drugs. In Helene Rush v. Wyeth, which started on Jan. 22, the plaintiff alleged she developed breast cancer from using Premarin and Prempro, the pharmaceutical company said.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Cases of wilful misrepresentation are a rarity in medical advertising. For every advertisement in which nonexistent doctors are called on to testify or deliberately irrelevant references are bunched up in [fine print], you will find a hundred or more whose greatest offenses are unquestioning enthusiasm and the skill to communicate it.

The best defence the physician can muster against this kind of advertising is a healthy skepticism and a willingness, not always apparent in the past, to do his homework. He must cultivate a flair for spotting the logical loophole, the invalid clinical trial, the unreliable or meaningless testimonial, the unneeded improvement and the unlikely claim. Above all, he must develop greater resistance to the lure of the fashionable and the new.
- Pierre R. Garai (advertising executive) 1963